Literature DB >> 6169659

Lymphocyte-dependent antibodies to antigen 3.1, a cell-surface antigen expressed by a subgroup of human melanomas.

I Hellström, K E Hellström, M Y Yeh.   

Abstract

Previous work from our laboratory has led to the isolation of a monoclonal IgG2a mouse antibody, 3.2, which is specific for an antigen, 3.1, that is strongest expressed by a group of human melanomas. We have no demonstrated that this antibody can mediate antibody-dependent cellular cytotoxicity (ADCC) to human melanoma cells expressing antigen 3., and that lymphocytes from human peripheral blood can be used as the source of K cells. A monoclonal IgG1 antibody, 3.1, to the same determinant of antigen 3.1 gave only weak and inconsistent ADCC.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169659     DOI: 10.1002/ijc.2910270305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

2.  A monoclonal antibody to the carbohydrate chain on human hepatocellular carcinoma-associated antigen which suppressed tumor growth in nude mice.

Authors:  Y Fukuda; K Imai; K Miura; M Matsui; T Nakanishi; H Nakazato; J Masukawa; T Higashide; Y Hinoda; T Noguchi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside.

Authors:  I Hellström; V Brankovan; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.

Authors:  I Hellström; P L Beaumier; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies.

Authors:  B S Wilson; G Ruberto; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

Authors:  J R Corvalan; W Smith
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 7.  Diagnostic and therapeutic use of monoclonal antibodies to human tumor antigens.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.

Authors:  T J Kipps; P Parham; J Punt; L A Herzenberg
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  Cellular cytotoxicity mediated by isotype-switch variants of a monoclonal antibody to human neuroblastoma.

Authors:  C H d'Uscio; T W Jungi; K Blaser
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.